EIGER BIOPHARMACEUTICALS, INC.

Profile

Company Names

EIGER BIOPHARMACEUTICALS, INC.
CELLADON CORP

Addresses

350 CAMBRIDGE AVE, SUITE 350, PALO ALTO, CA 94306

12760 HIGH BLUFF DRIVE, SUITE 240, SAN DIEGO, CA 92130

2223 AVENIDA DE LA PLAYA, SUITE 205, LA JOLLA, CA 92037

2223 AVENIDA DE LA PLAYA, SUITE 300, LA JOLLA, CA 92037

Phone Numbers

650-272-6138
858-366-4288

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

CALIFORNIA

Total Amount Raised:

$53,043,480.00

Number of Funding Rounds:

11
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
11
2016-04-20 
$2,999,982.00 
$3,000,000.00 
$18.00 
Equity 
10
2013-10-15 
$1,097,306.00 
$2,397,417.00 
$1,300,111.00 
Debt 
9
2012-01-27 
$19,466,190.00 
$64,537,095.00 
$45,070,905.00 
Equity 
8
2011-12-15 
$500,000.00 
$500,000.00 
$0.00 
Debt 
7
2011-11-08 
$330,000.00 
$500,000.00 
$170,000.00 
Debt 
6
2011-10-17 
$200,000.00 
$200,000.00 
$0.00 
Debt 
5
2011-08-25 
$250,000.00 
$250,000.00 
$0.00 
Debt 
4
2011-06-30 
$400,000.00 
$400,000.00 
$0.00 
Debt 
3
2010-08-11 
$2,500,000.00 
$4,000,000.00 
$1,500,000.00 
Debt 
2
2009-12-15 
$3,500,000.00 
$6,500,000.00 
$3,000,000.00 
Debt 
1
2008-03-19 
$21,800,002.00 
$24,631,114.00 
$2,831,112.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GREGG 
 
ALTON 
DIRECTOR
CELLADON CORP   |  COLLIDION INC.   |  RENOVARO INC.
FOUAD 
 
AZZAM 
DIRECTOR
HARVEST AUTOMATION INC   |  COBALT TECHNOLOGIES INC   |  CELLADON CORP   |  SEAHORSE BIOSCIENCE INC   |  ILLUMINOSS MEDICAL INC   |  ROTATION MEDICAL INC   |  BIOCLIN THERAPEUTICS, INC.   |  RAINIER THERAPEUTICS, INC.   |  NKARTA, INC.   |  ENDOTRONIX INC   |  EQT HEALTH ECONOMICS 3 COOPERATIEF U.A.   |  NEUROS MEDICAL, INC.
CHARLES 
 
BRAMLAGE 
DIRECTOR
PEARL THERAPEUTICS INC   |  EIGER BIOPHARMACEUTICALS, INC.
KENNETH 
R. 
CHIEN 
DIRECTOR
CELLADON CORP
GRAHAM 
 
COOPER 
DIRECTOR
CELLADON CORP   |  UNITY BIOTECHNOLOGY, INC.   |  BIONIZ THERAPEUTICS, INC.
DAVID 
A. 
CORY 
EXECUTIVE OFFICER, DIRECTOR
EIGER BIOPHARMACEUTICALS, INC.
BARBARA 
 
DALTON 
DIRECTOR
CELLADON CORP   |  CYDAN, LLC   |  LODO THERAPEUTICS CORP   |  PETRA PHARMA CORP   |  IMARA INC.   |  MORPHIC HOLDING, LLC   |  COMPLEXA INC.   |  CYDAN II, INC.   |  MAGNOLIA NEUROSCIENCES CORP
THOMAS 
J. 
DIETZ 
DIRECTOR
GALLEON PHARMACEUTICALS INC   |  EIGER BIOPHARMACEUTICALS, INC.
EDGAR 
G. 
ENGLEMAN 
DIRECTOR
CAPNIA, INC.   |  EIGER BIOPHARMACEUTICALS, INC.   |  BOLT BIOTHERAPEUTICS, INC.   |  SOLENO THERAPEUTICS INC
ANTHONY 
B. 
EVNIN 
DIRECTOR
ALTEA THERAPEUTICS CORP   |  CELLADON CORP   |  INFINITY PHARMACEUTICALS, INC.
TODD 
 
FOLEY 
DIRECTOR
RHYTHM PHARMACEUTICALS, INC.   |  ZALICUS INC.   |  CELLADON CORP   |  SELEXYS PHARMACEUTICALS CORP   |  PROTEON THERAPEUTICS INC   |  ICONIC THERAPEUTICS INC   |  VALERITAS INC   |  TETHEREX PHARMACEUTICALS CORP   |  CLINICAL INK, INC.   |  SEMMA THERAPEUTICS, INC.   |  RHYTHM METABOLIC, INC.   |  RHYTHM PHARMACEUTICALS, INC.   |  ENTRADA THERAPEUTICS, INC.   |  MOAT BIOTECHNOLOGY CORP   |  CROSSBOW THERAPEUTICS, INC.   |  FIREFLY BIO, INC.   |  AKTIS ONCOLOGY, INC.
JOSHUA 
 
FUNDER 
DIRECTOR
NUON THERAPEUTICS INC   |  PATHWAY THERAPEUTICS, INC.   |  CELLADON CORP   |  EUTHYMICS BIOSCIENCE INC   |  NEUROVANCE, INC.   |  EBI LIFE SCIENCES, INC.   |  SPINIFEX PHARMACEUTICALS INC
JEFFREY 
S. 
GLENN 
DIRECTOR
EIGER BIOPHARMACEUTICALS, INC.   |  4J THERAPEUTICS INC.
NINA 
 
KJELLSON 
DIRECTOR
LYCERA CORP   |  PRIMERA BIOSYSTEMS INC   |  PRIMERADX, INC.   |  ALVINE PHARMACEUTICALS INC   |  SEQUEL PHARMACEUTICALS INC   |  CNS THERAPEUTICS INC   |  TRIUS THERAPEUTICS INC   |  CEBIX INCOPRATED   |  CEBIX INC   |  EIGER BIOPHARMACEUTICALS INC   |  OCERA THERAPEUTICS INC   |  WELLTOK, INC.   |  OCERA THERAPEUTICS, INC.   |  K2 THERAPEUTICS, INC.   |  CIDARA THERAPEUTICS, INC.   |  EIGER BIOPHARMACEUTICALS, INC.   |  ANNUM HEALTH, INC.   |  VINETI, INC.   |  TYRA BIOSCIENCES, INC.
JOHAN 
 
KORDEL 
DIRECTOR
CELLADON CORP   |  RIVER VISION DEVELOPMENT CORP.   |  ICONIC THERAPEUTICS INC   |  CURZION PHARMACEUTICALS, INC.   |  AMPLYX PHARMACEUTICALS, INC.
REBECQUE 
 
LABA 
EXECUTIVE OFFICER
CELLADON CORP   |  VST BIO CORP
EDUARDO 
BRUNO 
MARTINS 
EXECUTIVE OFFICER
EIGER BIOPHARMACEUTICALS, INC.
MICHAEL 
 
NARACHI 
DIRECTOR
CELLADON CORP   |  OREXIGEN THERAPEUTICS, INC.
DANIEL 
 
OMSTEAD 
DIRECTOR
PALYON MEDICAL CORP   |  ELEME MEDICAL INC   |  CELLADON CORP   |  ILLUMINOSS MEDICAL INC   |  NEUROVANCE, INC.   |  INSIGHTRA MEDICAL, INC.   |  EUTHYMICS BIOSCIENCE, INC.
JOANNE 
 
QUAN 
EXECUTIVE OFFICER
EIGER BIOPHARMACEUTICALS, INC.
ANDREW 
E. 
SENYEI 
DIRECTOR
TARGEGEN INC   |  CELLADON CORP   |  ASCENTA THERAPEUTICS, INC.
JAMES 
P. 
SHAFFER 
EXECUTIVE OFFICER
EIGER BIOPHARMACEUTICALS, INC.
LAUREN 
 
SILVERMAN 
DIRECTOR
ASCENT THERAPEUTICS INC   |  VIAMET PHARMACEUTICALS INC   |  PULMATRIX INC   |  CEQUENT PHARMACEUTICALS INC   |  RA PHARMACEUTICALS, INC.   |  ANCHORTHERAPEUTICS, INC   |  CELLADON CORP   |  VIAMET PHARMACEUTICALS HOLDINGS LLC   |  AERPIO THERAPEUTICS, INC.   |  PROTEOSTASIS THERAPEUTICS, INC.
JAMES 
H. 
WELCH 
EXECUTIVE OFFICER
CERIMON PHARMACEUTICALS, INC.   |  ACELRX PHARMACEUTICALS INC   |  EIGER BIOPHARMACEUTICALS, INC.
ASISH 
 
XAVIER 
DIRECTOR
CELLADON CORP   |  AQUINOX PHARMACEUTICALS (USA) INC   |  AQUINOX PHARMACEUTICALS INC   |  ISCIENCE INTERVENTIONAL CORP   |  ISCIENCE INTERVENTIONAL CORP   |  CATALYST BIOSCIENCES INC   |  GENOCEA BIOSCIENCES, INC.   |  ALDEXA THERAPEUTICS, INC.   |  E-SCAPE BIO, INC.   |  LODO THERAPEUTICS CORP   |  PETRA PHARMA CORP   |  APOGEN BIOTECHNOLOGIES, INC.   |  RODEO THERAPEUTICS CORP   |  PRONIRAS CORP   |  MAGNOLIA NEUROSCIENCES CORP   |  VIACYTE INC.   |  ADICET BIO, INC.   |  ESCAPE BIO, INC.   |  IMMPACT BIO USA INC.   |  PAIGE.AI, INC.   |  SONOTHERA, INC.   |  BRIGHT PEAK THERAPEUTICS, INC.
KRISZTINA 
 
ZSEBO 
EXECUTIVE OFFICER, DIRECTOR
CELLADON CORP   |  VASORX, INC.   |  VST BIO CORP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-04-29
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2016-04-20 
2013-10-25
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2013-10-15 
2012-05-08
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-01-27 
2012-02-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-01-27 
2011-12-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-12-15 
2011-11-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-11-08 
2011-10-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-10-17 
2011-09-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-08-25 
2011-07-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2011-06-30 
2010-10-28
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2010-08-11 
2009-12-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2009-12-15 
2009-09-10
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2008-03-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#